Welcome to Shandong Zhonglian Chemical Co., Ltd. Equity Code:880747
21
2025
-
11
50 Core Q&As on Pharmaceutical-Grade silicon dioxide as a Pharmaceutical Excipient
Pharmaceutical-grade silicon dioxide (SiO₂) is an amorphous, white powdered inorganic compound that meets pharmaceutical excipient standards. It exhibits high purity, low impurities, excellent adsorption, and dispersibility.
1. Basic Understanding
1. What is pharmaceutical-grade silicon dioxide as a pharmaceutical excipient?
Pharmaceutical-grade silicon dioxide (SiO₂) is an amorphous, white powdered inorganic compound that meets pharmaceutical excipient standards. It exhibits high purity, low impurities, excellent adsorption, and dispersibility. Widely used as a functional excipient in pharmaceutical manufacturing, it primarily serves as a glidant, anti-caking agent, disintegrant, and stabilizer. It must comply with strict regulations from pharmacopeias worldwide, such as the Chinese Pharmacopoeia (ChP) and the United States Pharmacopeia (USP).
2. What are the core differences between pharmaceutical-grade silicon dioxide and food-grade silicon dioxide?
The key distinctions lie in purity standards, impurity limits, and application scenarios:
•Pharmaceutical-grade silicon dioxide requires pharmacopoeia-level purity (e.g., ChP mandates SiO₂ content ≥99.0%), with stricter limits on heavy metals (e.g., lead ≤1mg/kg) and additional tests for sterility and endotoxins.
•Food-grade silicon dioxide focuses on food safety with relatively lenient impurity limits, and its use is restricted to food processing—it is strictly prohibited for pharmaceutical applications.
3. What are the common physical forms of pharmaceutical-grade silicon dioxide?
It mainly exists in two forms:
•Powder form (e.g., precipitated or fumed silica): Used in tablets and capsules as glidants or anti-caking agents.
•Colloidal form (e.g., colloidal silica): Features finer (nanoscale) particles and stronger dispersibility, making it suitable as a stabilizer in oral suspensions or a thickener in topical medications.
4. What are the key chemical properties of pharmaceutical-grade silicon dioxide?
It has stable chemical properties: insoluble in water, dilute acids (except hydrofluoric acid), and organic solvents. It remains stable within a pH range of 2–10 and does not react with active pharmaceutical ingredients (APIs). Additionally, it exhibits good thermal stability and does not decompose during high-temperature pharmaceutical processes (typically ≤200℃), such as drying and tableting.
5. What is the significance of the "specific surface area" index for pharmaceutical-grade silicon dioxide?
Specific surface area (unit: m²/g) is a core indicator of adsorption and dispersibility:
•Products with high specific surface area (e.g., fumed silica, usually >100m²/g) have stronger adsorption capacity, making them suitable as disintegrants or stabilizers.
•Products with low specific surface area (e.g., some precipitated silica, <50m²/g) offer better flowability, ideal for use as glidants.
6. Why must pharmaceutical-grade silicon dioxide be in an "amorphous structure"?
Crystalline silica (e.g., quartz) has sharp crystalline structures that may cause lung damage with long-term inhalation and cannot be metabolized by the human body. In contrast, the amorphous structure eliminates such health risks while enabling adjustable dispersibility and adsorption through process control. All global pharmacopeias explicitly require the crystalline content of pharmaceutical-grade silicon dioxide to be ≤0.1%.
7. What functional roles does pharmaceutical-grade silicon dioxide play in pharmaceuticals?
Its core functions include:
1.Glidant: Improves powder flowability to ensure uniform dosing during tableting and capsule filling.
2.Anti-caking agent: Prevents pharmaceutical powders from absorbing moisture and caking.
3.Disintegrant: High-specific-surface-area products (e.g., fumed silica) absorb moisture to create pores, promoting rapid tablet disintegration and enhancing API dissolution.
4.Stabilizer: Adsorbs trace moisture and impurities in APIs or excipients to extend drug shelf life.
5.Suspending agent: Enhances the stability of oral liquid formulations and prevents API sedimentation.
8. How do different particle sizes of pharmaceutical-grade silicon dioxide affect their application scenarios?
Particle size (typically in μm) determines application scope:
•Small particle size (1–5μm): Colloidal silica, with strong dispersibility, is used for stabilizing oral suspensions and thickening topical ointments.
•Medium particle size (5–20μm): The most common specification, suitable as a glidant or anti-caking agent in tablets and capsules.
•Large particle size (20–50μm): Offers excellent flowability, ideal for filling high-density pharmaceutical powders........
Related Blog
Related Downloads
Service E-mail
Sales Add
Jinan City, Shandong Province,China
Production Add
Guangzhou City, Guangdong Province
